High blood pressure in young adults with obesity

Л. Хіміон, О. Рудь


The objective: to estimate the prevalence and distribution of arterial hypertension and risk factors of high blood pressure in young adults with overweight and obesity.

Patients and methods. The study was conducted in a group of 42 persons of both genders aged from 18 to 44 years: 22 patients were obese or overweight and 20 healthy controls with normal body mass index. The evaluation of the main (demographics, body mass index, lifestyle, lipids, blood pres sure) and additional (high sensitive C reactive protein, uric acid, insulin resistance) cardiovascular risk factors has been performed; the atherosclerosis development has been evalu ated by ultrasound method with measurement of the surro gate atherosclerosis markers (intima media thickness, ather osclerotic plaques in carotid arteries).

Results. High blood pressure (BP) was found in 5 (22,7%), smoking 16 (72,74%), sedentary lifestyle 13 (59%), dyslipi demia 8 (36,4%), hyperuricemia 5 (22,7%), prediabetes 8 (36,4%), insulin resistance state 4 (20%), thickening of IMT ≥ 0,9 mm in 10 (45,5%), atherosclerosis plaques in 5 (22,7%). Body mass index was strongly positively correlated to BP, plasma total cholesterol, low density cholesterol, plasma triglyceride and fasting glucose level, also the medium positive correlation was estimated between HOMA index and CRP level (r=0,39), which could be the sign of higher subclinical level of inflammatory process in obese and overweigh patients which further influences the atherosclerosis development.

Conclusion. High blood pressure was more frequent in sub jects with overweight and obesity than in controls. In group of patients with overweight and obesity the most frequent risk factors were dyslipidemia and smoking


arterial hypertension; obesity

Full Text:



Castellon X. Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors / X. Castellon, V. Bogdanova // Clin. Interv. Aging. – 2013. – No 8. – P. 573–580.

Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376:1670–1681.

Early atherosclerosis detection in asymptomatic patients: a comparison of carotid ultrasound, coronary artery calcium score, and coronary computed tomography angiography /B. Schroeder, G. Francis, J. Leipsic [et al.]// Can. J. Cardiol. – 2013. – Vol. 29, No 12. – P. 1687–1694.

Effects of dietary approaches to stop hypertension (DASH) style diet on fatal or nonfatal cardiovascular diseases incidence: a systematic review and

meta analysis on observational prospective studies / A. Salehi Abargouei, Z. Maghsoudi, F. Shirani, L. Azadbakht //Nutrition. – 2013. – Vol. 29, No 4. – P. 611–618.

Heart disease and stroke statistics 2012 update: a report from the American Heart Association / V.L. Roger, A.S. Go, D.M. Lloyd Jones [et al.] // Circulation. – 2012. – Vol. 125, No 1. – P. e2-e220.].

Klein S, Allison DB, Heysfield SB, Kelley DE, Leibel RL, Nomas C et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping Americaґs Health: Association for Weight Management and Obesity Prevention, NAASO, The Obesity Society; the American Society for Nutrition, and the American Diabetes Association. Am J Clin Nutr 2007;85:1197–1202.

Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors and oxidative stress during adolescence. Circulation 2005;111:1985–1991.

Townsend N, Nichols M, Scarborough P, Rayner M. Cardiovascular disease in Europe – epidemiological update 2015. Eur Heart J 2015; 36: 2696–2705.

ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Eur. Heart J. – 2013. – Vol. 34. – P. 2159–2219.

Артеріальна гіпертензія. Оновлена та адаптована клінічна настанова, заснована на доказах (2012 рік): практичні рекомендації / Робоча група з артеріальної гіпертензії Укр. асоц. кардіологів // Артериальная гипертензия. – 2012. – No 1. – С. 96–152.

Бильченко А.В. Новые европейские рекомендации ESH/ESC 2013 по

лечению артериальной гипертензии / А.В. Бильченко // Здоров’я України. Тематичний номер «Кардіологія. Ревматологія. Кардіохірургія». – 2013. – No 3 (28). – С. 10–11.

Коваленко В.М. Національна стратегія боротьби з артеріальної гіпертензії в Україні: соціальні та медичні аспекти / В.М. Коваленко // 2012.

Copyright (c) 2020 Л. Хіміон, О. Рудь

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

ISSN 2412-8708 (Online), ISSN 2307-5112 (Print)

Flag Counter

ISSN (print): 2307-5112.